[Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of thrombocyte function inhibitors].
D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control*; D010644:Phenprocoumon / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects*; D012008:Recurrence
D010644:Phenprocoumon; D001241:Aspirin
Pro--Kontra: Antikoagulantien oder Thrombozytenfunktionshemmer in der Prophylaxe des Herzinfarktes? Argumente für Thrombozytenfunktionshemmer.